Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-11 Sale |
2023-08-11 4:10 pm |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
12,169 | $0 | $0 | 0 (Direct) |
View |
| 2023-06-08 Purchase |
2023-06-09 08:00 am |
Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director |
5,000 | $22.06 | $110,300 | 5,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-06 Option Award |
2025-03-10 6:00 pm |
N/A N/A |
Viatris Inc | VTRS | Vivaldi Coelho Rogerio Director |
23,660 | $0 | 23,660 (Direct) |
View |
| 2025-03-04 Exercise |
2025-03-05 7:00 pm |
N/A N/A |
Viatris Inc | VTRS | Vivaldi Coelho Rogerio Director |
22,114 | $0 | 21,691 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:21 pm |
N/A 2034-06-07 |
Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director |
15,900 | $0 | 26,900 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-04 6:05 pm |
N/A N/A |
Viatris Inc | VTRS | Vivaldi Coelho Rogerio Director |
21,267 | $0 | 21,267 (Direct) |
View |
| 2023-07-21 Exercise |
2023-07-24 7:44 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
5,528 | $19.24 | 24,126 (Direct) |
View |
| 2023-07-21 Exercise |
2023-07-24 7:44 pm |
N/A 2032-02-17 |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
5,528 | $0 | 24,126 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director |
23,500 | $0 | 28,500 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-01 4:43 pm |
N/A 2033-02-27 |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
460,000 | $0 | 460,000 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 4:47 pm |
N/A 2032-06-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director |
8,750 | $0 | 8,750 (Direct) |
View |
| 2022-01-03 Option Award(A) |
2022-04-04 7:08 pm |
N/A 2031-12-31 |
Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-22 5:00 pm |
N/A 2032-02-17 |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
230,000 | $1.48 | 230,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-10 4:34 pm |
N/A 2031-12-31 |
Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 4:15 pm |
N/A 2032-01-02 |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
400,000 | $3.03 | 400,000 (Direct) |
View |
| 2021-11-04 Option Award |
2021-11-05 4:15 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
50,000 | $0 | 73,461 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 08:00 am |
N/A 2031-02-10 |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
200,000 | $0 | 200,000 (Direct) |
View |
| 2020-12-08 Conversion |
2020-12-10 6:13 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio President and CEO |
22,222 | $0 | 22,222 (Direct) |
View |
Ownership |
2020-12-03 8:42 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio President and CEO |
0 | $0 | 1,112,221 (Direct) |
View |